Progesterone Offers No Significant Benefit after Traumatic Brain Injury
Treatment of acute traumatic brain injury with the hormone progesterone provides no significant benefit to patients, a National Institutes of Health-funded phase III clinical trial has concluded. The results were published recently in the New England Journal of Medicine. Banner – University Medical Center Tucson was one of 49 trauma centers that participated in the study.
